IPHYF Innate Pharma SA
NEUTRAL
Impact: 2/10
6-K
Notable filing: 6-K
Latest settled — T+20d
IPHYF ▲ +50.00% at T+20d
NEUTRAL call ✓ call won +50.00% · α vs SPY +45.37% · entry $1.50 → $2.25
Last close $1.65 (close Jun 12) · +10.00% from $1.50 entry
T+1d
0.00%
call 0.00% · α -0.78%
$1.50
settled 7w ago
T+5d
0.00%
call 0.00% · α -1.48%
$1.50
settled 7w ago
T+20d
+50.00%
call +50.00% · α +45.37%
$2.25
settled 25d ago
T+60d
—
call — · α —
—
in 5w
Price Chart
Loading chart...
Executive Summary
Innate Pharma announced executive participation in the D. Boral Capital Global Conference on May 7, 2026, for investor meetings. This is a routine investor relations update with no new financial or clinical data disclosed.
Actionable Insight
Monitor for any updates or commentary from management during the conference, but expect minimal immediate market impact. The event may provide insight into the company's strategy amid its ongoing funding concerns highlighted in the prior 20-F filing.
Key Facts
- Company to participate in D. Boral Capital Global Conference on May 7, 2026, in New York
- No new clinical, financial, or operational updates provided
- Event involves one-on-one investor meetings, not a public presentation
Financial Impact
No immediate financial impact
Risk Factors
- Continued uncertainty around financing needs for lacutamab development
- No substantive update provided; reliance on future disclosures for material information
Market Snapshot
Exchange
OTC
Sector
Biological Products, (No Diagnostic Substances)
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001628280-26-026676 |
| Document: a6k-iphx260423.htm | 0001628280-26-026676 |
| Document: 0001628280-26-026676-index-headers.html | 0001628280-26-026676 |
| Document: 0001628280-26-026676-index.html | 0001628280-26-026676 |
| Document: 0001628280-26-026676.txt | 0001628280-26-026676 |
10 reports for IPHYF
33%
Hit rate
best @ T+20▲ +50.00%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 19, 2026
26d ago
|
6-K
| $2.25 $1.65 | ▼ −26.67% | ▼ −28.96% | $1.65 (−26.67%) |
|
May 13, 2026
4w ago
|
6-K
| $1.50 $2.25 | ▼ −50.00% | ▼ −51.16% | $1.65 (−10.00%) |
|
May 6, 2026
5w ago
|
6-K
| $1.50 $1.50 | · 0.00% | ▼ −1.13% | $1.65 (+10.00%) |
|
Apr 23, 2026
7w ago
|
6-K
| $1.50 $1.50 | · 0.00% | ▼ −1.48% | $1.65 (+10.00%) |
|
Apr 17, 2026
8w ago
|
6-K
| $1.50 $1.50 | · 0.00% | ▼ −0.55% | $1.65 (+10.00%) |
|
Apr 13, 2026
8w ago
|
6-K
| $1.37 $1.50 | ▲ +9.25% | ▲ +5.95% | $1.65 (+20.17%) |
|
Apr 13, 2026
8w ago
|
6-K
| $1.37 $1.50 | ▲ +9.25% | ▲ +5.95% | $1.65 (+20.17%) |
|
Apr 8, 2026
9w ago
|
6-K
| $1.37 $1.50 | ▲ +9.25% | ▲ +5.73% | $1.65 (+20.17%) |
|
Apr 3, 2026
10w ago
|
6-K
| $1.37 $1.37 | · 0.00% | ▼ −4.13% | $1.65 (+20.17%) |
|
Apr 1, 2026
10w ago
|
20-F
| $1.37 $1.37 | · 0.00% | ▲ +3.77% | $1.65 (−20.17%) |
Showing 10 of 10
US Market Status
Market Closed — Opens in 5h 3m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access